RARE DISEASERESEARCH ATLAS
Open navigation menu

ORPHA:45452

Idiopathic neonatal atrial flutter

high confidenceDisorder

Publications

27

37.1th percentile

Trials

0

Interventional, condition-specific

Researchers

126

Distinct authors in sample

Gene link

—

Readiness

2/6

Stages with a signal

Clinical definition (Orphanet)

atrial flutter (AFL) is a rare rhythm disorder, characterized by sustained tachycardia in newborns and infants with an atrial rate often at around 440 beats/minute (range 340-580). AFL may manifest as asymptomatic tachycardia, congestive heart failure or hydrops.

How rare: How common this is has not been clearly measured.

Orphanet entry

Cross-references

Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.

Additional Mondo synonyms (1)

neonatal cardiac dysrhythmia

Research stages

Trial readiness signals

Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”

2/6 stages with a signal

No specific-condition interventional trial, but broader-category trials exist — discuss eligibility with a clinician.

  1. Gene identifiedNot found

    No GenCC disease–gene assertion in this build

  2. LiteraturePresent

    27 matched papers (20 in last 10 years) Source

  3. Phenotype characterisedNot checked

    Not yet enriched from Monarch / HPO

  4. Animal modelNot checked

    Not yet enriched from Monarch / Alliance

  5. Orphan designationNot checked

    FDA/EMA orphan-drug designation not enriched yet

  6. Interventional trialPartial

    None under the specific name; 155 for broader category atrial flutter

Biology

Genes and phenotypes

Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.

Do we know what causes it?

Not yet — the cause hasn't been pinned down in GenCC.

No strong gene–disease assertion joined for this Orphanet entity.

Phenotypes (Monarch / HPO)

Not enriched in this build — Monarch phenotype joins were not run for this record.

Animal models (Monarch / Alliance)

Not enriched in this build.

Literature

Is anyone studying this?

27

27 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.

27 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).

20 in the last 10 years · high confidence · 37.1th percentile (publications denominator)

Phrase hits: 27 · MeSH hits: 0

Open Europe PMC search

Who's working on it?

126

Distinct author names in 27 sampled papers — named people below.

Who's working on it?

No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.

  1. 01
    Tesfay N4 papers · 2023

    Centre of Public Health Emergency Management, Ethiopian Public Health Institutes, Addis Ababa, Ethiopia.

    Papers in Europe PMC
  2. 02
    Woldeyohannes F4 papers · 2023

    Health Financing Program, Clinton Health Access Initiative, Addis Ababa, Ethiopia.

    Papers in Europe PMC
  3. 03
    Hailu G2 papers · 2023

    Centre of Public Health Emergency Management, Ethiopian Public Health Institutes, Addis Ababa, Ethiopia.

    Papers in Europe PMC
  4. 04
    Tariku R2 papers · 2023

    Centre of Public Health Emergency Management, Ethiopian Public Health Institutes, Addis Ababa, Ethiopia.

    Papers in Europe PMC
  5. 05
    Zenebe A2 papers · 2023

    Centre of Public Health Emergency Management, Ethiopian Public Health Institutes, Addis Ababa, Ethiopia.

    Papers in Europe PMC
  6. 06
    Al-Shehri H1 paper · 2023

    Department of Pediatrics, College of Medicine, Imam Mohammad Ibn Saud Islamic University, Riyadh, Saudi Arabia.

    Papers in Europe PMC
  7. 07
    Aminu M1 paper · 2019

    Centre for Maternal and Newborn Health, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.

    Papers in Europe PMC
  8. 08
    Andrade RFS1 paper · 2023

    Center of Data and Knowledge Integration for Health (CIDACS), Gonçalo Moniz Institute, Oswaldo Cruz Foundation, Salvador, Bahia, Brazil.

    Papers in Europe PMC
  9. 09
    Aravindan N1 paper · 2025

    Department of Obstetrics & Gynecology, North Shore University Hospital & Long Island Jewish Medical Center, Manhasset, NY 11030, USA.

    Papers in Europe PMC
  10. 10
    Bajolle F1 paper · 2011
    Papers in Europe PMC

Clinical research

Is a treatment being tested?

0

interventional trials for this specific condition

No interventional trial testing a treatment matched this specific condition name. 1 observational study did — shown below because natural-history and cohort work can be an important step toward a trial. 155 trials are registered for atrial flutter, the broader category — shown separately because they may or may not enrol this specific subtype.

Data as of 27 July 2026

No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.

high confidence · 36.5th percentile (trials denominator)

Recruiting interventional trials

From the matched ClinicalTrials.gov set

No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.

155 interventional trials matched atrial flutter, the broader category — listed below. Those studies are not counted in the condition-specific total.

Broader category: atrial flutter

155

Interventional trials for the parent category, exclusive of NCT IDs already counted above. Eligibility for this subtype is not guaranteed.

Worth raising with a clinician. How we count trials.

Recruiting under the broader category

Observational and natural-history studies

1 observational study matches this condition. These do not test a treatment and are not counted in the interventional-trial headline, but they are genuine research: natural-history work often defines the endpoints needed for a future rare-disease trial, and families may be able to enroll.

Recruiting or not-yet-recruiting

Open the complete matched search on ClinicalTrials.gov

Where to find support

We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:

India — NPRD

Last verified 2026-07-26

This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.

Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.

How we counted this

Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.

"Idiopathic neonatal atrial flutter" OR "neonatal cardiac dysrhythmia"

Run this search on Europe PMC

ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):

"Idiopathic neonatal atrial flutter" OR "neonatal cardiac dysrhythmia" OR "idiopathic disease"

Recall-expansion terms: idiopathic disease

Study-type breakdown: 0 interventional · 1 observational · 0 expanded access. Only interventional studies enter the trial headline.

Parent-category trials query:

"atrial flutter"

Query health: ok — strategies attempted: phrase, recall-expansion; with hits: phrase, recall-expansion

Run this search on ClinicalTrials.gov

Confidence reasoning

  • Preferred label is multi-word and distinctive
  • No synonyms dropped by stoplist
  • No label/synonym collisions with other diseases in this corpus

Ingested 2026-07-27T00:08:30.719Z